How many institutions held FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in Q2 2020?

199 institutional investors reported FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share for Q2 2020. Use the holders table for investor-level position and value details.

FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

Q: What does CUSIP 31189P102 represent in this 13F holders report?

CUSIP 31189P102 is the security identifier for FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 31189P102

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 114,331,829
Total 13F shares: 85,944,579
Share change: +10,242,614
Total reported value: $2,946,905,994
Put/Call ratio: 114%
Price per share: $34.31
Number of holders: 199
Value change: +$357,311,792
Number of buys: 127
Number of sells: 61

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 31189P102:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2020

As of 30 Jun 2020, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 199 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,944,579 shares. The largest 10 holders included Redmile Group, LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, FARALLON CAPITAL MANAGEMENT LLC, Johnson & Johnson Innovation - JJDC, Inc., CITADEL ADVISORS LLC, STATE STREET CORP, and Casdin Capital, LLC. This page lists 199 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.